The Current and Future Place of Vinorelbine in Cancer Therapy

Cancer: Principles and Practice of Oncology.

1991 • 8,402 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

[Cancer of the lung].

1954 • 861 citations

Cisplatin : current status and new developments

1980 • 746 citations

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

1988 • 704 citations

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

1986 • 337 citations

Chemotherapy of ovarian cancer

1998 • 303 citations

Vincristine treatment of advanced cancer: a cooperative study of 392 cases.

1973 • 234 citations

Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.

1976 • 197 citations

High-dose carboplatin in refractory ovarian cancer patients.

1987 • 151 citations

The clinical pharmacology of etoposide

1991 • 136 citations

Phase-II study of Navelbine in advanced breast cancer.

1989 • 132 citations

FAILURE OF CHEMOTHERAPY TO PROLONG SURVIVAL IN A GROUP OF PATIENTS WITH METASTATIC BREAST CANCER

1980 • 129 citations

Experimental antitumor activity of Navelbine.

1989 • 127 citations

The synthesis of Navelbine prototype of a new series of vinblastine derivatives.

1989 • 112 citations

Chemotherapy of breast cancer: Current views and results

1983 • 104 citations

A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloids

1979 • 96 citations

In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence.

1989 • 93 citations

Tubulin aggregation and disaggregation: mediation by two distinct vinblastine-binding sites.

1976 • 92 citations

Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.

1989 • 91 citations

Experience of a German multicenter study group with ifosfamide in small cell lung cancer.

1989 • 86 citations

Phase I pharmacologic study of a new Vinca alkaloid: Navelbine

1985 • 80 citations

Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.

1991 • 79 citations

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment

1985 • 77 citations

Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer.

1980 • 63 citations

Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats

1986 • 61 citations

Analysis of vinca alkaloids in plasma and urine using high-performance liquid chromatography with electrochemical detection

1988 • 60 citations

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).

1987 • 58 citations

Chemotherapy of breast cancer

1984 • 54 citations

Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).

1989 • 50 citations

Etoposide. Current and future status

1991 • 47 citations

Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine).

1984 • 47 citations

Phase II evaluation of vindesine in patients with non-small cell carcinoma of the lung.

1979 • 46 citations

Five-day continuous-infusion vinblastine in the treatment of breast cancer

1985 • 45 citations

The pharmacology of intravenous and oral etoposide

1991 • 41 citations

A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma

1985 • 40 citations

Phase II study of mitoxantrone in epithelial ovarian cancer.

1987 • 34 citations

Chemotherapy of breast cancer a general overview

1983 • 33 citations

Critical Review of Pharmacology, Toxicology, Pharmacokinetics of Vincristine, Vindesine, Vinblastine

1981 • 33 citations

Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.

1981 • 28 citations

Vinca alkaloids in the treatment of non-small cell lung cancer

1987 • 26 citations

Pharmacokinetics of navelbine after oral administration in cancer patients

1991 • 25 citations

Phase II study of vindesine in patients with advanced breast cancer.

1982 • 25 citations

A multicenter phase II study of carboplatin in advanced ovarian carcinoma: Final report

1992 • 15 citations

[Analytical limits in clinical pharmacokinetics: example of vinca-alkaloids].

1991 • 3 citations

Vindesine in the Treatment of Lung Cancer — a Review

1981 • 1 citations

Critical Review on the Use of Vindesine in the Treatment of Lung Cancer

1981 • 1 citations